[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

Search Results (173)

Search Parameters:
Keywords = TAC1B

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
14 pages, 1468 KiB  
Article
The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women—A Pilot Randomized Clinical Trial
by Araceli Montoya-Estrada, Aline Yunuen García-Cortés, José Romo-Yañez, Guillermo F. Ortiz-Luna, Arturo Arellano-Eguiluz, Aurora Belmont-Gómez, Vivian Lopéz-Ugalde, Guadalupe León-Reyes, Arturo Flores-Pliego, Aurora Espejel-Nuñez, Juan Mario Solis-Paredes and Enrique Reyes-Muñoz
Nutrients 2024, 16(21), 3775; https://doi.org/10.3390/nu16213775 - 3 Nov 2024
Viewed by 1666
Abstract
In postmenopausal women, due to endocrine changes, there is an increase in oxidative stress (OS) that predisposes them to cardiovascular and metabolic alterations. Sixty-one percent of women in this stage require a primary therapeutic strategy to decrease OS. This study aimed to evaluate [...] Read more.
In postmenopausal women, due to endocrine changes, there is an increase in oxidative stress (OS) that predisposes them to cardiovascular and metabolic alterations. Sixty-one percent of women in this stage require a primary therapeutic strategy to decrease OS. This study aimed to evaluate the effect of resveratrol and vitamin C on OS in postmenopausal women. A randomized, double-blind clinical trial was carried out. Forty-six postmenopausal women with insulin resistance (HOMA-IR > 2.5) were included and divided into three treatment groups: group A: resveratrol, n = 13; group B: resveratrol + vitamin C, n = 15; and group C: vitamin C, n = 14. Between before and after the antioxidants, group B showed a decrease of 33% in lipohydroperoxides (p = 0.02), and malondialdehyde (MDA) decreased by 26% (p = 0.0007), 32% (p = 0.0001), and 38% (p = 0.0001) in groups A–C, respectively. For protein damage, group B is the most representative, with a decrease of 39% (p = 0.0001). For total antioxidant capacity (TAC), there were significant increases of 30% and 28% in groups B and C, respectively. For HOMA-IR, there were no significant differences among the study groups. Supplementation with this combination of antioxidants significantly decreases markers of OS in postmenopausal women. In addition, it increases TAC by up to 30%. Full article
(This article belongs to the Section Phytochemicals and Human Health)
Show Figures

Figure 1

Figure 1
<p>Flowchart of the participants in the study.</p>
Full article ">Figure 2
<p>LHP concentration before and after treatment in postmenopausal women with insulin resistance. Resveratrol group, <span class="html-italic">n</span> = 13; resveratrol and vitamin C group, <span class="html-italic">n</span> = 15; and vitamin C group, <span class="html-italic">n</span> = 14. The results obtained were analyzed using Student’s “t”. Data are presented as mean ± standard deviation. * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 3
<p>MDA concentrations before and after treatment in postmenopausal women with insulin resistance. Resveratrol group, <span class="html-italic">n</span> = 13; resveratrol and vitamin C group, <span class="html-italic">n</span> = 15; and vitamin C group, <span class="html-italic">n</span> = 14. The results obtained were analyzed using Student’s “t”. Data are presented as mean ± standard deviation. ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 4
<p>Protein carbonylation concentration before and after treatment in postmenopausal women with insulin resistance. Resveratrol group, <span class="html-italic">n</span> = 13; resveratrol and vitamin C group, <span class="html-italic">n</span> = 15; and vitamin C group, <span class="html-italic">n</span> = 14. The results obtained were analyzed using Student’s “t”. Data are presented as mean ± standard deviation. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 5
<p>Total antioxidant capacity before and after treatment in postmenopausal women with insulin resistance. Resveratrol group, <span class="html-italic">n</span> = 13; resveratrol and vitamin C group, <span class="html-italic">n</span> = 15; and vitamin C group, <span class="html-italic">n</span> = 14. The results obtained were analyzed using Student’s “<span class="html-italic">t</span>” test. Data are presented as mean ± standard deviation. * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 6
<p>HOMA-IR before and after treatment in postmenopausal women with insulin resistance. Resveratrol group, <span class="html-italic">n</span> = 13; resveratrol and vitamin C group, <span class="html-italic">n</span> = 15; and vitamin C group, <span class="html-italic">n</span> = 14. The results obtained were analyzed using Student’s “t”. Data are presented as mean ± standard deviation.</p>
Full article ">
12 pages, 1070 KiB  
Article
CYP3A4*1B but Not CYP3A5*3 as Determinant of Long-Term Tacrolimus Dose Requirements in Spanish Solid Organ Transplant Patients
by Julia Concha, Estela Sangüesa, María Pilar Ribate and Cristina B. García
Int. J. Mol. Sci. 2024, 25(20), 11327; https://doi.org/10.3390/ijms252011327 - 21 Oct 2024
Viewed by 819
Abstract
Tacrolimus (TAC) is a commonly used immunosuppressive drug in solid organ transplantation. Pharmacogenetics has been demonstrated before to be decisive in TAC pharmacotherapy. The CYP3A5*3 variant has been reported to be the main determinant of TAC dose requirements; however, other polymorphisms have also [...] Read more.
Tacrolimus (TAC) is a commonly used immunosuppressive drug in solid organ transplantation. Pharmacogenetics has been demonstrated before to be decisive in TAC pharmacotherapy. The CYP3A5*3 variant has been reported to be the main determinant of TAC dose requirements; however, other polymorphisms have also proven to be influential, especially in CYP3A5 non-expressor patients. The aim of this study is to evaluate the influence of genetic polymorphisms in TAC therapy in a cohort of Spanish transplant recipients. Genetic analysis including ten polymorphic variants was performed, and demographic and clinical data and pharmacotherapy of 26 patients were analyzed. No significant differences were found in weight-adjusted dose between CYP3A5 expressors and non-expressors (0.047 mg/kg vs. 0.044 mg/kg), while they were found for carriers of the CYP3A4*1B allele (0.101 mg/kg; p < 0.05). The results showed that patients with at least one CYP3A4*1B allele had a higher TAC dose and lower blood concentration. Dose-adjusted TAC blood levels were also lower in CYP3A4*1B carriers compared to non-carriers (0.72 ng/mL/mg vs. 2.88 ng/mL/mg). These results support the independence of CYP3A5*3 and CYP3A4*1B variants as determinants of dose requirements despite the linkage disequilibrium present between the two. The variability in genotype frequency between ethnicities may be responsible for the discrepancy found between studies. Full article
(This article belongs to the Special Issue Pharmacogenomics, 3rd Edition)
Show Figures

Figure 1

Figure 1
<p>TAC pathways of absorption, metabolism, and excretion.</p>
Full article ">Figure 2
<p>Weight-adjusted dose for each genotypic group (rs2740574).</p>
Full article ">Figure 3
<p>Co/dose for each genotypic group (rs2740574). ** TAC Blood levels were obtained in a limited number of patients.</p>
Full article ">
12 pages, 1199 KiB  
Article
Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus/Mycophenolate/Steroids Maintenance Immunosuppression
by Florian Lacave, Christophe de Terwangne, Tom Darius, Antoine Buemi, Michel Mourad, Yannick France, Joana Cardoso Coelho, Guillaume Fernandes, Eric Goffin, Arnaud Devresse and Nada Kanaan
J. Clin. Med. 2024, 13(20), 6151; https://doi.org/10.3390/jcm13206151 - 16 Oct 2024
Viewed by 937
Abstract
Background: Induction therapy with basiliximab is recommended in kidney transplant (KT) recipients with a low immunological risk (LIR) profile. Whether basiliximab is associated with a decreased risk of acute rejection (AR) and graft loss is controversial. Methods: In our institution, LIR [...] Read more.
Background: Induction therapy with basiliximab is recommended in kidney transplant (KT) recipients with a low immunological risk (LIR) profile. Whether basiliximab is associated with a decreased risk of acute rejection (AR) and graft loss is controversial. Methods: In our institution, LIR patients (absence of anti-HLA antibodies before KT) are inducted with basiliximab in case of living-donor KT, while deceased-donor KT recipients receive no induction. Maintenance immunosuppression is similar, including a combination of tacrolimus (Tac), mycophenolate (MPA) and steroids. In this single-center retrospective study, we included all adult LIR patients who underwent KT between 1 January 2015 and 31 December 2022. Results: Of the 471 patients included, 354 received no induction and 117 received basiliximab. The median (IQR) number of HLA A-B-DR mismatches was 3 (2–3) and 2 (2–4) in the no induction group and the basiliximab group, respectively. The cumulative incidences in the no induction group vs. the basiliximab group of acute rejection and graft loss over 5 years post-KT were similar at 8.9% vs. 7.8% (p = 0.8) and 8.5% vs. 4.2% (p = 0.063), respectively. In multivariable Cox regression analysis, delayed graft function emerged as an independent risk factor for acute rejection (hazard ratio [HR] 2.75, 95% confidence interval [CI] 1.23–6.13, p = 0.014) and graft loss (HR 9.32, CI 4.10–21.1, p < 0.001). Conclusions: Basiliximab did not provide any advantage in terms of rate of acute rejection and graft survival within 5 years post KT compared with a strategy without induction therapy in patients with a low immunological risk profile receiving triple maintenance immunosuppression Tac/MPA/steroids. Full article
(This article belongs to the Special Issue Updates on Renal Transplantation and Its Complications)
Show Figures

Figure 1

Figure 1
<p>Flowchart of the study.</p>
Full article ">Figure 2
<p>Cumulative incidence of acute rejection over 5 years (<b>A</b>) and over 1 year (<b>B</b>) after transplantation.</p>
Full article ">Figure 3
<p>Trends in eGFR in the first year after transplantation.</p>
Full article ">Figure 4
<p>Cumulative incidence of graft loss over 5 years after transplantation.</p>
Full article ">
13 pages, 64133 KiB  
Article
A Tribological Study of ta-C, ta-C:N, and ta-C:B Coatings on Plastic Substrates under Dry Sliding Conditions
by Paul Neubauer, Frank Kaulfuss and Volker Weihnacht
Lubricants 2024, 12(10), 331; https://doi.org/10.3390/lubricants12100331 - 27 Sep 2024
Viewed by 633
Abstract
In this study, we analyze the extent to which thin hard coatings can serve as tribological protective layers for the selected plastic substrate materials PA12 (polyamide 12) und PEEK (polyetheretherketone), with and without fiber reinforcement. The approximately 1 µm thick coating variants ta-C, [...] Read more.
In this study, we analyze the extent to which thin hard coatings can serve as tribological protective layers for the selected plastic substrate materials PA12 (polyamide 12) und PEEK (polyetheretherketone), with and without fiber reinforcement. The approximately 1 µm thick coating variants ta-C, ta-C:N, and ta-C:B, which were applied using the laser arc process, are investigated. In oscillating sliding wear tests against a steel ball in an air atmosphere without lubricant, the wear of the coating and counter body is compared to analogous coating variants applied in parallel to AISI 52100 steel. The ta-C-based coatings show good adhesion strength and basic suitability as wear protection layers on the plastic substrates in the tribological tests. However, there are variations depending on the coating type and substrate material. The use of a Cr interlayer and its thickness also plays an important role. It is demonstrated that by coating under conditions where the uncoated plastic substrate would normally fail, a similarly good performance as with analogously coated steel substrates can be achieved by ta-C:N. Full article
(This article belongs to the Special Issue Tribology in Germany: Latest Research and Development)
Show Figures

Figure 1

Figure 1
<p>Microscopic images of the PA12, PA12-GF30, PEEK, and PEEK-CF30 uncoated (<b>left</b>), and 1 µm ta-C-coated (<b>right</b>) substrates in bright field (<b>top</b>) and with differential interference contrast (DIC) filter (<b>bottom</b>).</p>
Full article ">Figure 2
<p>Arithmetic mean deviation Sa (<b>top</b>) and surface defect fraction (SDF) (<b>bottom</b>) for AISI 52100, PA12, PA12-GF30, PEEK, and PEEK-CF30 uncoated and coated with 1 µm ta-C, 1 µm ta-C:N, and 1 µm ta-C:B.</p>
Full article ">Figure 3
<p>Steel-ball counter-body wear measured after tribotests with set I.</p>
Full article ">Figure 4
<p>Comparison of friction coefficients (<b>left</b>) and coating/surface wear behavior between ta-C:N-coated steel (black) and PEEK (blue) vs. an uncoated PEEK (red) sample (<b>right</b>).</p>
Full article ">Figure 5
<p>Visualization of the calculated stress distribution of the normal stress σ<sub>z</sub> for three different substrate materials with 1 µm ta-C coating vs. steel ball with 1 N and 10 N normal load (<b>a</b>) and distribution of σ<sub>z</sub> at z = 0 in x-directions at 10 N normal load (<b>b</b>).</p>
Full article ">
20 pages, 1378 KiB  
Article
Phytochemical Composition Antioxidant and Anti-Inflammatory Activity of Artemisia dracunculus and Artemisia abrotanum
by Mădălina Țicolea, Raluca Maria Pop, Marcel Pârvu, Lia-Oxana Usatiuc, Ana Uifălean, Floricuța Ranga and Alina Elena Pârvu
Antioxidants 2024, 13(8), 1016; https://doi.org/10.3390/antiox13081016 - 20 Aug 2024
Cited by 1 | Viewed by 1079
Abstract
This study aimed to investigate the antioxidant and anti-inflammatory activities mechanism of Artemisia dracunculus (A. dracunculus) and Artemisia abrotanum (A. abrotanum) ethanol extracts in acute rat inflammation induced in Wistar male rats with turpentine oil. The characterization of the [...] Read more.
This study aimed to investigate the antioxidant and anti-inflammatory activities mechanism of Artemisia dracunculus (A. dracunculus) and Artemisia abrotanum (A. abrotanum) ethanol extracts in acute rat inflammation induced in Wistar male rats with turpentine oil. The characterization of the polyphenolic compounds in the extracts was conducted using UV–Vis and Fourier-transform infrared spectroscopy and high-performance liquid chromatography coupled with mass spectrometry techniques. The antioxidant activity of the extracts was evaluated in vitro by DPPH, FRAP, H2O2, and NO scavenging tests and in vivo by measuring the total oxidative status (TOS), total antioxidant capacity (TAC), oxidative stress index (OSI), 8-hydroxy-deoxyguanosine (8-Oxo-dG), advanced oxidation protein products (AOPP), malondialdehyde (MDA), nitric oxide (NO), 3-nitrotyrosine (3NT), and total thiols (SH). Inflammation was evaluated by measuring nuclear factor-kB-p65 (NfkB-p65) and NLRP3 inflammasome activation with IL-1β, IL-18, and gasdermin D. Liver and renal toxicity was determined following transaminases (ALT and AST), creatinine, and urea. The experimental results indicated that A. dracunculus and A. abrotanum ethanol extracts have moderate in vitro antioxidant activity and had in vivo antioxidant activity and an anti-inflammatory effect by NfkB-p65, IL-1b, IL-18, and gasdermin D serum level reduction. The antioxidant activity correlated with the chemical composition of the extracts. These results bring evidence-based use of A. dracunculus and A. abrotanum’s in traditional and contemporary medicine. Full article
Show Figures

Figure 1

Figure 1
<p>HPLC chromatogram of phenolic compounds from <span class="html-italic">A. abrotanum</span> and <span class="html-italic">A. dracunculus</span> ethanolic extracts. The peak identification is provided in <a href="#antioxidants-13-01016-t002" class="html-table">Table 2</a>.</p>
Full article ">Figure 2
<p>Comparative general FTIR spectra of <span class="html-italic">A. dracunculus</span> and <span class="html-italic">A. abrotanum</span> ethanol extracts (600–3500 cm<sup>−1</sup>).</p>
Full article ">Figure 3
<p>The PCA results of oxidative stress and inflammatory biomarkers based on the correlation matrix with PC1 and PC2 for <span class="html-italic">A. dracunculus</span> and <span class="html-italic">A. abrotanum</span> ethanol extracts: (<b>A</b>) PCA of AD 100%; (<b>B</b>) PCA of AD 50%; (<b>C</b>) PCA of AD 25%; (<b>D</b>) PCA of AA 100%; (<b>E</b>) PCA of AA 50%; (<b>F</b>) PCA of AA 25%. AD 100%—<span class="html-italic">A. dracunculus</span> 100%; AD 50%—<span class="html-italic">A. dracunculus</span> 50%; AD 25%—<span class="html-italic">A. dracunculus</span> 25%; AA 100%—<span class="html-italic">A. abrotanum</span> 100%; AA 50%—<span class="html-italic">A. abrotanum</span> 50%; AA 25%—<span class="html-italic">A. abrotanum</span> 25%.</p>
Full article ">Figure 3 Cont.
<p>The PCA results of oxidative stress and inflammatory biomarkers based on the correlation matrix with PC1 and PC2 for <span class="html-italic">A. dracunculus</span> and <span class="html-italic">A. abrotanum</span> ethanol extracts: (<b>A</b>) PCA of AD 100%; (<b>B</b>) PCA of AD 50%; (<b>C</b>) PCA of AD 25%; (<b>D</b>) PCA of AA 100%; (<b>E</b>) PCA of AA 50%; (<b>F</b>) PCA of AA 25%. AD 100%—<span class="html-italic">A. dracunculus</span> 100%; AD 50%—<span class="html-italic">A. dracunculus</span> 50%; AD 25%—<span class="html-italic">A. dracunculus</span> 25%; AA 100%—<span class="html-italic">A. abrotanum</span> 100%; AA 50%—<span class="html-italic">A. abrotanum</span> 50%; AA 25%—<span class="html-italic">A. abrotanum</span> 25%.</p>
Full article ">
9 pages, 1149 KiB  
Article
Effects of Bosentan on Hypoxia, Inflammation and Oxidative Stress in Experimental Blunt Thoracic Trauma Model
by Nedim Uzun, Sinem Durmus, Gonca Gercel, Burhan Aksu, Naile Fevziye Misirlioglu and Hafize Uzun
Medicina 2024, 60(7), 1148; https://doi.org/10.3390/medicina60071148 - 17 Jul 2024
Cited by 1 | Viewed by 918
Abstract
Background and Objectives: In this study, we aimed to investigate the effects of bosentan, an endothelin receptor antagonist, on endothelin-1 (ET-1), hypoxia-inducible factor-1 (HIF-1), nuclear factor-kappa B (NF-κB), and tumor necrosis factor (TNF)-α as inflammation markers, pro-oxidant antioxidant balance (PAB), and total antioxidant [...] Read more.
Background and Objectives: In this study, we aimed to investigate the effects of bosentan, an endothelin receptor antagonist, on endothelin-1 (ET-1), hypoxia-inducible factor-1 (HIF-1), nuclear factor-kappa B (NF-κB), and tumor necrosis factor (TNF)-α as inflammation markers, pro-oxidant antioxidant balance (PAB), and total antioxidant capacity (TAC) levels as oxidative stress parameters in lung tissues of rats in an experimental model of pulmonary contusion (PC) induced by blunt thoracic trauma. Materials and Methods: Thirty-seven male Sprague-Dawley rats were divided into five groups. C: The control group (n = 6) consisted of unprocessed and untreated rats. PC3 (n = 8) underwent 3 days of PC. PC-B3 (n = 8) received 100 mg/kg bosentan and was given orally once a day for 3 days. The PC7 group (n = 7) underwent 7 days of PC, and PC-B7 (n = 8) received 100 mg/kg bosentan and was given orally once a day for 7 days. Results: ET-1, NF-κB, TNF-α, HIF-1α, and PAB levels were higher, while TAC activity was lower in all groups compared with the control (p < 0.05). There was no significant difference in ET-1 and TNF-α levels between the PC-B3 and PC-B7 groups and the control group (p < 0.05), while NF-κB, HIF-1α, and PAB levels were still higher in both the PC-B3 and PC-B7 groups than in the control group. Bosentan decreased ET-1, NF-κB, TNF-α, HIF-1α, and PAB and increased TAC levels in comparison to the nontreated groups (p < 0.05). Conclusions: Bosentan decreased the severity of oxidative stress in the lungs and reduced the inflammatory reaction in rats with PC induced by blunt thoracic trauma. This suggests that bosentan may have protective effects on lung injury mechanisms by reducing hypoxia, inflammation, and oxidative stress. If supported by similar studies, bosentan can be used in both pulmonary and emergency clinics to reduce ischemic complications, inflammation, and oxidative stress in some diseases that may be accompanied by ischemia. Full article
(This article belongs to the Section Emergency Medicine)
Show Figures

Figure 1

Figure 1
<p>Flowchart of the experimental protocol.</p>
Full article ">Figure 2
<p>Comparative Levels of Rat Lung Tissue (<b>A</b>) Endothelin-1 (ET-1), (<b>B</b>) Hypoxia-Inducible Factor-1 (HIF-1)-α, (<b>C</b>) Nuclear Factor-kappa B (NF-κB), (<b>D</b>) Tumor Necrosis Factor (TNF)-α, (<b>E</b>) Ferric Reducing Antioxidant Power (FRAP) and (<b>F</b>) Prooxidant-Antioxidant Balance (PAB)across Control (<span class="html-italic">n</span> = 6), 3 Days Pulmonary contusion (PC) Performed (PC3, <span class="html-italic">n</span> = 8), PC3 with 100 mg/kg Bosentan (PC-B3, <span class="html-italic">n</span> = 8), 7 Days PC Performed (PC7, <span class="html-italic">n</span> = 7), and PC7 with 100 mg/kg Bosentan (PC-B7, <span class="html-italic">n</span> = 8) groups. Significant differences are indicated as follows: “a” indicates a significant difference compared to the control group, “b” indicates a significant difference compared to the PC3 group, and “c” indicates a significant difference compared to the PC7 group. * Means <span class="html-italic">p</span> &lt; 0.05, ** means <span class="html-italic">p</span> &lt; 0.01, and *** means <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">
21 pages, 8347 KiB  
Article
Neuroprotection of Transcranial Cortical and Peripheral Somatosensory Electrical Stimulation by Modulating a Common Neuronal Death Pathway in Mice with Ischemic Stroke
by Hongju Lee, Juyeon Lee, Dahee Jung, Harim Oh, Hwakyoung Shin and Byungtae Choi
Int. J. Mol. Sci. 2024, 25(14), 7546; https://doi.org/10.3390/ijms25147546 - 9 Jul 2024
Viewed by 1444
Abstract
Therapeutic electrical stimulation, such as transcranial cortical stimulation and peripheral somatosensory stimulation, is used to improve motor function in patients with stroke. We hypothesized that these stimulations exert neuroprotective effects during the subacute phase of ischemic stroke by regulating novel common signaling pathways. [...] Read more.
Therapeutic electrical stimulation, such as transcranial cortical stimulation and peripheral somatosensory stimulation, is used to improve motor function in patients with stroke. We hypothesized that these stimulations exert neuroprotective effects during the subacute phase of ischemic stroke by regulating novel common signaling pathways. Male C57BL/6J mouse models of ischemic stroke were treated with high-definition (HD)-transcranial alternating current stimulation (tACS; 20 Hz, 89.1 A/mm2), HD-transcranial direct current stimulation (tDCS; intensity, 55 A/mm2; charge density, 66,000 C/m2), or electroacupuncture (EA, 2 Hz, 1 mA) in the early stages of stroke. The therapeutic effects were assessed using behavioral motor function tests. The underlying mechanisms were determined using transcriptomic and other biomedical analyses. All therapeutic electrical tools alleviated the motor dysfunction caused by ischemic stroke insults. We focused on electrically stimulating common genes involved in apoptosis and cell death using transcriptome analysis and chose 11 of the most potent targets (Trem2, S100a9, Lgals3, Tlr4, Myd88, NF-kB, STAT1, IL-6, IL-1β, TNF-α, and Iba1). Subsequent investigations revealed that electrical stimulation modulated inflammatory cytokines, including IL-1β and TNF-α, by regulating STAT1 and NF-kB activation, especially in amoeboid microglia; moreover, electrical stimulation enhanced neuronal survival by activating neurotrophic factors, including BDNF and FGF9. Therapeutic electrical stimulation applied to the transcranial cortical- or periphery-nerve level to promote functional recovery may improve neuroprotection by modulating a common neuronal death pathway and upregulating neurotrophic factors. Therefore, combining transcranial cortical and peripheral somatosensory stimulation may exert a synergistic neuroprotective effect, further enhancing the beneficial effects on motor deficits in patients with ischemic stroke. Full article
(This article belongs to the Special Issue New Molecular Insights into Ischemia/Reperfusion)
Show Figures

Figure 1

Figure 1
<p>Effects of therapeutic electrical stimulation on motor restoration in ischemic stroke. (<b>A</b>) Experimental schedule and schematic images of electrical stimulation. Quantification of the results of behavioral testing, including the (<b>B</b>) Rotarod, (<b>C</b>) Wire-grip, (<b>D</b>) Open-field, and (<b>E</b>) Catwalk tests. All electrical stimulations significantly improved motor dysfunction compared with MCAO. All data are expressed as mean ± standard error of the mean (n = 6/group); * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001 vs. each group using one-way analysis of variance with Tukey’s test. Dot color means light grey, Control; dark grey, MCAO; Green, MCAO + tACS; Blue, MCAO + tDCS; Pupple, MCAO + EA group.</p>
Full article ">Figure 2
<p>Analysis of quantitative RNA-seq to identify potent signaling pathways induced by therapeutic electrical stimulation in ischemic stroke. (<b>A</b>) Experimental schedule and schematic images of RNA-seq. (<b>B</b>) Venn diagram of DEGs in each group. Red/blue font means number of up-/down regulated genes. (<b>C</b>) Bubble plot of the top 10 KEGG pathways using 544 downregulated DEGs. Larger bubbles indicate a higher number of genes. The color of each bubble represents the <span class="html-italic">p</span>-value. (<b>D</b>) Upper panel: bar chart of common DEG categories, including 30 up- and 544 downregulated DEGs. Lower panel: bar chart of the cell death category using common DEGs, including 30 up- and 544 downregulated DEGs. The common genes are mainly related to apoptosis, autophagy, and phagocytosis. (<b>E</b>) Protein–protein interaction network analysis of commonly expressed genes in apoptosis, autophagy, and phagocytosis and (<b>F</b>) ClueGO analysis results of biological interactions. Each group includes three mice. RNA-seq, ribonucleic acid sequencing; DEGs, differentially expressed genes; KEGG, Kyoto Encyclopedia of Genes and Genomes.</p>
Full article ">Figure 3
<p>Effects of therapeutic electrical stimulation on inflammatory cytokines and related signaling pathways in ischemic stroke. (<b>A</b>) Western blot and quantification of S100a9, Trem2, Tlr4, and Myd88. (<b>B</b>) Western blot and corresponding bar graphs of p-SATA1/STAT1 and p-NF-kB/NF-kB in the nucleus and cytoplasm. (<b>C</b>) Western blot and corresponding quantification of IL-1β, Iba1, and TNF-α. These findings revealed that electrical stimulation in an ischemic stroke model decreased the levels of cytokines such as IL-1β and TNF-α by modulating STAT1 and NF-kB activation. All data are expressed as mean ± standard error of the mean (n = 6/group); * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001 vs. each group using one-way analysis of variance with Tukey’s test. White dot means individual values. MCAO, middle cerebral artery occlusion.</p>
Full article ">Figure 4
<p>Effect of therapeutic electrical stimulation on IL-1β production and related factors in activated microglia in ischemic stroke. (<b>A</b>) Effect of electrical stimulations on microglia morphology in the ischemic stroke model. (<b>B</b>) Photomicrographs and corresponding quantification of Iba1/p-STAT1 double-positive cells in the perilesional cortex. (<b>C</b>) Photomicrographs and corresponding bar graphs of Iba1/p-NF-kB double-positive cells. (<b>D</b>) Photomicrographs and corresponding bar charts of Iba1/IL-1β double-positive cells. Activated microglia are shown in amoeboid (white arrows) and bushy (yellow arrows) forms. Amoeboid and bushy microglia were present in the MCAO surgery groups, and compared with the MCAO group, the amoeboid form decreased significantly in the MCAO + tACS and MCAO + tDCS groups. The number of Iba1/p-STAT1, Iba1/p-NF-kB, and Iba1/IL-1β double-positive cells, as well as the percentage of cells, in amoeboid microglia are significantly decreased in all electrically stimulated groups. All data are expressed as mean ± standard error of mean (n = 6/group); * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001 vs. each group using one-way analysis of variance with Tukey’s test. Scale bars, 30 and 50 μm. White dot means individual values. MCAO, middle cerebral artery occlusion.</p>
Full article ">Figure 5
<p>Effect of therapeutic electrical stimulation on neuronal survival and neurotrophic factors in ischemic stroke. (<b>A</b>) Photomicrographs and corresponding quantification of Iba1/c-Casp3 double-positive cells (white arrows) in the perilesional cortex. (<b>B</b>) Bar chart and Venn diagram of categories and heat map of neurotrophic factors using common DEGs of electrical stimulation. (<b>C</b>) Western blot and corresponding bar graphs of BDNF and FGF9. (<b>D</b>) Photomicrographs and corresponding quantification of BDNF- and FGF9-positive cells in the perilesional cortex (white arrows, BDNF/FGF9-, yellow arrows, FGF9-, and orange arrows, BDNF-positive cells). All electrical stimulations significantly increase the expression of neurotrophic factors, such as BDNF and FGF9, in ischemic stroke and are involved in neuronal survival. All data are expressed as mean ± standard error of the mean (n = 6/group); * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001 vs. each group using one-way analysis of variance with Tukey’s test. Scale bars, 30 and 50 μm. Red/blue font means number of up-/down regulated genes. White dot means individual values. MCAO, middle cerebral artery occlusion.</p>
Full article ">Figure 6
<p>Effect of peripheral somatosensory stimulation by electroacupuncture (EA) on the EEG of the cortical in ischemic stroke. (<b>A</b>) Computational modeling of transcranial alternating- and direct current-stimulations. The predicted electrical fields are mainly observed around the targeted electrode area, with a higher relative peak electric potential and current density than other cortices. (<b>B</b>) Representative traces and spectrogram of each group. Orange: control; red: MCAO; blue: 0 min (immediately after EA stimulation; green: 30 min after EA stimulation; violet: 1 h after EA stimulation. (<b>C</b>) Line graph and area quantification of amplitude based on frequency. Brain oscillation in a lesional cortex of the ischemic model is altered by EA stimulation. EA stimulation changed brain oscillation in the ischemic stroke model. All data are expressed as mean ± standard error of the mean (n = 3/group); * <span class="html-italic">p</span> &lt; 0.05, and *** <span class="html-italic">p</span> &lt; 0.001 vs. each group using one-way analysis of variance with Tukey’s test. Color bar means light grey, Control; dark grey, MCAO; Green, MCAO + tACS; Blue, MCAO + tDCS; Pupple, MCAO + EA group. White dot means individual values. EEG, electroencephalogram; MCAO, middle cerebral artery occlusion.</p>
Full article ">
19 pages, 6250 KiB  
Article
Enhancing Ablation Resistance of TaB2-Based Ultra-High Temperature Ceramics by Mixing Fine TaC Particles and Dispersed Multi-Walled Carbon Nanotubes
by Guangxu Bo, Xiaoke Tian, Huanhuan Li, Luona Ye, Xiaoling Xu, Zhaorui Gu, Jinyong Yan, Xingjian Su and Yunjun Yan
Materials 2024, 17(14), 3394; https://doi.org/10.3390/ma17143394 - 9 Jul 2024
Viewed by 759
Abstract
Ultra-high temperature ceramics (UHTCs) have been widely applied in many fields. In order to enhance the comprehensive properties of TaB2-based UHTCs, the first collaborative use of fine TaC particles and dispersed multi-walled carbon nanotubes (MWCNTs) was employed via spark plasma sintering [...] Read more.
Ultra-high temperature ceramics (UHTCs) have been widely applied in many fields. In order to enhance the comprehensive properties of TaB2-based UHTCs, the first collaborative use of fine TaC particles and dispersed multi-walled carbon nanotubes (MWCNTs) was employed via spark plasma sintering (SPS) at 1700 °C. The derived UHTCs exhibited an average grain size of 1.3 μm, a relative density of 98.6%, an elastic modulus of 386.3 GPa, and a nano hardness of 21.7 GPa, leading to a greatly improved oxidation resistance with a lower linear ablation rate at −3.3 × 10−2 μm/s, and a markedly reinforced ablation resistance with mass ablation rate of −1.3 × 10−3 mg/(s·cm2). The enhanced ablation resistance was attributable to the physical pinning effect, sealing effect and self-healing effect. Thus, this study provides a potential strategy for preparation of UHTCs with bettered ablation resistance and physical properties. Full article
Show Figures

Figure 1

Figure 1
<p>The microstructure of the pure TaB<sub>2</sub> powder (<b>a</b>), pure TaC powder (<b>b</b>), 95TaB<sub>2</sub>-5TaC powder (<b>c</b>), 95TaB<sub>2</sub>-5TaC-0.5MWCNTs powder (<b>d<sub>1</sub></b>,<b>d<sub>2</sub></b>) and 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA powder (<b>e<sub>1</sub></b>,<b>e<sub>2</sub></b>).</p>
Full article ">Figure 2
<p>XRD curves of pure TaB<sub>2</sub> powder (<b>a</b>), 95TaB<sub>2</sub>-5TaC powder (<b>b</b>), 95TaB<sub>2</sub>-5TaC-0.5MWCNTs powder (<b>c</b>), and 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA powder (<b>d</b>), and pure TaC powder (<b>e</b>).</p>
Full article ">Figure 3
<p>XRD curves of pure TaB<sub>2</sub> (<b>a</b>), 95TaB<sub>2</sub>-5TaC (<b>b</b>), 95TaB<sub>2</sub>-5TaC-0.5MWCNTs (<b>c</b>), and 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA (<b>d</b>).</p>
Full article ">Figure 4
<p>The microstructure of the pure TaB<sub>2</sub> (<b>a<sub>1</sub></b>,<b>a<sub>2</sub></b>), 95TaB<sub>2</sub>-5TaC (<b>b<sub>1</sub></b>,<b>b<sub>2</sub></b>), 95TaB<sub>2</sub>-5TaC-0.5MWCNTs (<b>c<sub>1</sub></b>,<b>c<sub>2</sub></b>), and 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA (<b>d<sub>1</sub></b>,<b>d<sub>2</sub></b>).</p>
Full article ">Figure 5
<p>TGA curves (<b>a</b>) and DTG curves (<b>b</b>) of the UHTCs under air.</p>
Full article ">Figure 6
<p>XRD curves of ablative pure TaB<sub>2</sub> (<b>a</b>), ablative 95TaB<sub>2</sub>-5TaC (<b>b</b>), ablative 95TaB<sub>2</sub>-5TaC-0.5MWCNTs (<b>c</b>), and ablative 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA (<b>d</b>).</p>
Full article ">Figure 7
<p>The surface microstructure of the ablative pure TaB<sub>2</sub> (<b>a<sub>1</sub></b>,<b>a<sub>2</sub></b>), ablative 95TaB<sub>2</sub>-5TaC (<b>b<sub>1</sub></b>,<b>b<sub>2</sub></b>), ablative 95TaB<sub>2</sub>-5TaC-0.5MWCNTs (<b>c<sub>1</sub></b>,<b>c<sub>2</sub></b>), and ablative 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA (<b>d<sub>1</sub></b>,<b>d<sub>2</sub></b>).</p>
Full article ">Figure 8
<p>FESEM image (<b>a</b>) and EDXS elemental mapping (<b>b</b>–<b>e</b>) of the surface microstructure of the ablative 95TaB<sub>2</sub>-5TaC, FESEM image (<b>f</b>), and EDXS elemental mapping (<b>g</b>–<b>j</b>) of the surface microstructure of ablative 95TaB<sub>2</sub>-5TaC-0.5MWCNTs, with EDXS patterns of the selected regions in <a href="#materials-17-03394-f007" class="html-fig">Figure 7</a> (<b>k</b>–<b>n</b>).</p>
Full article ">Figure 9
<p>The vertical cross-sectional microstructure of ablative pure TaB<sub>2</sub> (<b>a<sub>1</sub></b>,<b>a<sub>2</sub></b>), ablative 95TaB<sub>2</sub>-5TaC (<b>b<sub>1</sub></b>,<b>b<sub>2</sub></b>), ablative 95TaB<sub>2</sub>-5TaC-0.5MWCNTs (<b>c<sub>1</sub></b>,<b>c<sub>2</sub></b>), and ablative 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA (<b>d<sub>1</sub></b>,<b>d<sub>2</sub></b>).</p>
Full article ">Figure 10
<p>FESEM image (<b>a</b>) and EDXS elemental mapping (<b>b</b>–<b>e</b>) of the vertical cross-sectional microstructure of the ablative 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA, with the EDXS patterns of the selected regions in <a href="#materials-17-03394-f009" class="html-fig">Figure 9</a> (<b>f</b>,<b>g</b>).</p>
Full article ">Scheme 1
<p>Schematic diagram of the ablative mechanism of the 95TaB<sub>2</sub>-5TaC-0.5MWCNTs-0.2PAA.</p>
Full article ">
20 pages, 1781 KiB  
Article
Levels of Different Microbial Groups on Inert Surfaces of Poultry Slaughterhouses: Identification Using Matrix-Assisted Laser Desorption Ionization Time-of-Flight and Detection of Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Enterobacteria
by Sarah Panera-Martínez, Cristina Rodríguez-Melcón, Daniel Rodríguez-Campos, Nuria Pérez-Estébanez, Rosa Capita and Carlos Alonso-Calleja
Antibiotics 2024, 13(7), 587; https://doi.org/10.3390/antibiotics13070587 - 25 Jun 2024
Viewed by 965
Abstract
Knowledge of the microbiota present in food processing environments is a significant advance that will allow for better evaluation of the risk of food contamination and a better design of the procedures for sanitization. The levels of microbial group indicators of hygienic quality [...] Read more.
Knowledge of the microbiota present in food processing environments is a significant advance that will allow for better evaluation of the risk of food contamination and a better design of the procedures for sanitization. The levels of microbial group indicators of hygienic quality were determined in different areas of the slaughter lines of two poultry slaughterhouses in the northwest of Spain (22 surfaces in each slaughterhouse were studied). The average microbial levels (cfu/cm2) were 2.15 × 102 ± 4.26 × 102 (total aerobic counts, TAC), 1.99 × 102 ± 5.00 × 102 (psychrotrophic microorganisms), 3.10 × 100 ± 1.37 × 101 (enterobacteria), 3.96 × 100 ± 2.55 × 101 (coliforms), 1.80 × 10−1 ± 7.79 × 10−1 (enterococci), and 1.12 × 10−1 ± 3.35 × 10−1 (vancomycin-resistant enterococci, VRE). TAC and psychrotrophic microorganisms were the most abundant groups in all samples (p < 0.05). The counts of both microbial groups were higher (p < 0.05) in samples of Slaughterhouse A than in those of Slaughterhouse B. Microbial loads for the rest of the bacteria were not influenced by the slaughterhouse sampled (p > 0.05). All 44 samples showed TAC and psychrotrophic microorganisms. Colonies of the rest of the microbial groups were only found in 26 samples (59.1% of the total). The isolates (one from each sample) were identified with MALDI-TOF and PCR. Gram-negative bacteria (all Enterobacteriaceae) were isolated in 23 samples, and Gram-positive bacteria were isolated in 16 (9 Enterococcus spp., 2 Enterococcus spp. and VRE, 3 VRE, 1 Enterococcus spp. and Listeria spp., and 1 Listeria spp.). The resistance of the strains to 11 (Enterococcus spp.) or 17 (Enterobacteriaceae) antibiotics was determined (disk diffusion, CLSI), finding an average of 2.05 ± 2.06 resistances per strain (3.46 ± 2.27 if reduced susceptibility reactions are included). A total of 37.3% of the Enterobacteriaceae isolates had a gene for resistance to beta-lactam antibiotics (blaTEM, blaCTX-M-15, blaKPC, blaCMY-2 or blaNDM). The high prevalence of resistant bacteria and resistance genes highlights the need to establish measures to control the spread of antibiotic resistance in poultry slaughterhouses. The findings of this work could contribute to the design of more effective sanitation procedures. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Average percentages of resistant, intermediate (with reduced susceptibility), and susceptible strains in the different microbial groups studied.</p>
Full article ">Figure 2
<p>Percentage of resistant <span class="html-italic">E. coli</span> strains, with reduced susceptibility or susceptibility to each of the antibiotics tested. Gentamicin, 10 µg (CN10), kanamycin, 30 µg (K30), streptomycin, 10 µg (S10), amoxicillin/clavulanic acid, 30 µg (AMC30), ampicillin, 10 µg (AMP10), ceftazidime, 30 µg (CAZ30), cefotaxime, 30 µg (CTX30), cefoxitin, 30 µg (FOX30), meropenem, 10 µg (MEM10), aztreonam, 30 µg (ATM30), chloramphenicol, 30 µg (C30), ciprofloxacin, 5 µg (CIP5), nalidixic acid, 30 µg (NA30), sulfamethoxazole/trimethoprim, 25 µg (SXT25), tetracycline, 30 µg (TE30), fosfomycin, 50 µg (FOS50), nitrofurantoin, 300 µg (F300).</p>
Full article ">Figure 3
<p>Percentage of resistant <span class="html-italic">Enterobacteriaceae</span> strains other than <span class="html-italic">E. coli</span>, with reduced susceptibility or susceptibility to each of the antibiotics tested. Gentamicin, 10 µg (CN10), kanamycin, 30 µg (K30), streptomycin, 10 µg (S10), amoxicillin/clavulanic acid, 30 µg (AMC30), ampicillin, 10 µg (AMP10), ceftazidime, 30 µg (CAZ30), cefotaxime, 30 µg (CTX30), cefoxitin, 30 µg (FOX30), meropenem, 10 µg (MEM10), aztreonam, 30 µg (ATM30), chloramphenicol, 30 µg (C30), ciprofloxacin, 5 µg (CIP5), nalidixic acid, 30 µg (NA30), sulfamethoxazole/trimethoprim, 25 µg (SXT25), tetracycline, 30 µg (TE30), fosfomycin, 50 µg (FOS50), nitrofurantoin, 300 µg (F300).</p>
Full article ">Figure 4
<p>Percentage of <span class="html-italic">Enterococcus</span> spp. strains resistant, intermediate (with reduced susceptibility), or susceptible to each of the antibiotics tested. Ampicillin, 10 µg (AMP10), chloramphenicol, 30 µg (C30), erythromycin, 15 µg (E15), fosfomycin, 50 µg (FOS50), quinupristin/dalfopristin, 15 µg (QD15), linezolid, 10 µg (LZD10), nitrofurantoin, 300 µg (F300), rifampicin, 5 µg (RD5), teicoplanin, 30 µg (TEC30), tetracycline, 30 µg (TE30), and vancomycin, 30 µg (VA).</p>
Full article ">Figure 5
<p>Distribution of beta-lactam antibiotic resistance genes among <span class="html-italic">Escherichia</span> and the rest of <span class="html-italic">Enterobacteriaceae</span> (other than <span class="html-italic">E. coli</span>) isolated on surfaces in both slaughterhouses.</p>
Full article ">
13 pages, 535 KiB  
Article
The Importance of the FUT2 rs602662 Polymorphism in the Risk of Cardiovascular Complications in Patients after Kidney Transplantation
by Maciej Józef Kotowski, Piotr Ostrowski, Jerzy Sieńko, Bogusław Czerny, Karol Tejchman, Bogusław Machaliński, Aleksandra Górska, Aleksandra E. Mrozikiewicz and Anna Bogacz
Int. J. Mol. Sci. 2024, 25(12), 6562; https://doi.org/10.3390/ijms25126562 - 14 Jun 2024
Viewed by 1178
Abstract
The FUT2 gene encodes an enzyme called α-1,2-fucosyltransferase, which is involved in the formation of blood group antigens AB0(H) and is also involved in the processes of vitamin B12 absorption and its transport between cells. FUT2 gene polymorphisms are associated with vitamin B12 [...] Read more.
The FUT2 gene encodes an enzyme called α-1,2-fucosyltransferase, which is involved in the formation of blood group antigens AB0(H) and is also involved in the processes of vitamin B12 absorption and its transport between cells. FUT2 gene polymorphisms are associated with vitamin B12 levels in the body. Vitamin B12 deficiency associated with hyperhomocysteinemia is a major risk factor for cardiovascular diseases (CVDs), which are one of the main causes of death in patients after kidney transplantation. The aim of our study was to determine the impact of the rs602662 (G>A) polymorphism of the FUT2 gene on the functionality of transplanted kidneys and the risk of CVD in patients after kidney transplantation. The study included 402 patients treated with immunosuppression (183 patients taking cyclosporine (CsA) and 219 patients taking tacrolimus (TAC)). The analysis of the FUT2 rs602662 (G>A) polymorphism was performed using real-time PCR. Patients with CsA were more likely to be underweight (1.64% vs. 0.91%) and obese (27.87% vs. 15.98%), while those taking TAC were more likely to be of normal weight (39.27%) or overweight (43.84%). No statistically significant differences were observed comparing the mean blood pressure, both systolic and diastolic. The renal profile showed a higher median urea nitrogen concentration in patients with CsA (26.45 mg/dL (20.60–35.40) vs. 22.95 mg/dL (17.60–33.30), p = 0.004). The observed frequency of rs602662 alleles of the FUT2 gene was similar in the analyzed groups. The A allele was present in 43.7% of patients with CsA and 41.1% of those taking TAC (OR = 0.898; 95% CI: 0.678–1.189; p = 0.453). In the group with CsA, the GG genotype was present in 32.2% of patients, the GA in 48.1% and the AA in 19.7%. A similar distribution was obtained in the TAC group: GG—33.8%, GA—50.2%, and AA—16.0%. An association of genotypes containing the G allele with a higher incidence of hypertension was observed. The G allele was present in 65% of people with hypertension and in 56% of patients with normal blood pressure (p = 0.036). Moreover, the evaluation of the renal parameters showed no effect of the FUT2 polymorphism on the risk of organ rejection because the levels of creatinine, eGFR, potassium, and urea nitrogen were prognostic of successful transplantation. Our results suggest that the rs6022662 FUT2 polymorphism may influence the risk of cardiovascular diseases. Full article
Show Figures

Figure 1

Figure 1
<p>Percentage distribution of rs602662 alleles of the <span class="html-italic">FUT2</span> gene and arterial hypertension in the entire group of 402 patients after kidney transplantation.</p>
Full article ">
12 pages, 1035 KiB  
Article
Effects of Congested Matches and Training Schedules on Salivary Markers in Elite Futsal Players
by Alejandro Soler-López, Carlos D. Gómez-Carmona, Adrián Moreno-Villanueva, Ana M. Gutiérrez and José Pino-Ortega
Appl. Sci. 2024, 14(12), 4968; https://doi.org/10.3390/app14124968 - 7 Jun 2024
Viewed by 794
Abstract
A congested match and training schedule could alter internal load, and this could be reflected in biomarkers of stress and immunity in elite futsal players. The aim of this study was to analyze the effects of a congested match and training schedule on [...] Read more.
A congested match and training schedule could alter internal load, and this could be reflected in biomarkers of stress and immunity in elite futsal players. The aim of this study was to analyze the effects of a congested match and training schedule on internal load and levels of total protein, total oxidant status (TOS), total antioxidant capacity (TAC), oxidative stress index, and the concentrations of salivary immunoglobulin A (SIgA) in 17 professional players from the same Portuguese elite futsal club (age: 23.07 ± 6.76 years old; height: 1.75 ± 0.06 m; body mass: 75.47 ± 7.47 kg; experience in playing in elite: 5.38 ± 2.03 years) who performed 5 matches and 16 training sessions in a period of 27 days. The salivary content of total protein, TOS, TAC, oxidative stress index, and SIgA were calculated before and after the training sessions and the unofficial matches under study. Saliva sampling was conducted 10 min before each match or training session and 40 min after (post-match and post-training). The MANOVA of repeated measures showed a significant difference for total protein and SIgA (p < 0.01). Total protein (sphericity = 0.007; statistical power = 0.818) and SIgA (sphericity = 0.018; statistical power = 0.693) are highly correlated with the time factor. The main findings revealed several key points: (a) There was a significant increase in total protein, SIgA, and TAC during acute load (pre- vs. post-session) in both training and match contexts. Specifically, total protein and SIgA displayed notable increments in both training and match settings, while TAC exhibited significant increases exclusively during matches. (b) No changes in TOS and oxidative stress index were observed during acute load in either training or match contexts. (c) A positive trend was noted between the chronic load during a congested week of the precompetitive season and the decrease in total protein and SIgA levels. (d) Additionally, a positive correlation between internal training loads and oxidative/antioxidant responses was found, as expressed by the oxidative stress index, without significant differences (p-value > 0.05) in acute and chronic loads during congested matches and training schedules. Full article
(This article belongs to the Section Applied Biosciences and Bioengineering)
Show Figures

Figure 1

Figure 1
<p>Acute fatigue (pre- vs. post-session) in training and match contexts in immunological and oxidative variables. <b>Notes:</b> SIgA: salivary immunoglobulin A; TOS: total oxidant status; TAC: total antioxidant capacity. * indicates statistical significance set at a <span class="html-italic">p</span>-value of ≤ 0.05. Cohen’s d is interpreted by the authors as: * small (<span class="html-italic">d</span> = 0.2 to 0.49), ** medium (<span class="html-italic">d</span> = 0.5 to 0.79), and *** large (<span class="html-italic">d</span> ≥ 0.8).</p>
Full article ">Figure 2
<p>Immunological and oxidative marker dynamics in four moments throughout the congested fixture period (pre-: pre-match; post-: post-match; 48 h: 48-h after the match; 120 h: 120-h after the match). <b>Notes:</b> SIgA: salivary immunoglobulin A; TOS: total oxidant status; TAC: total antioxidant capacity. α: Statistical differences from the pre-match condition (<span class="html-italic">p</span> &lt; 0.05); β: Statistical differences from the post-match condition (<span class="html-italic">p</span> &lt; 0.05); γ: Statistical differences 48-h after match condition (<span class="html-italic">p</span> &lt; 0.05); δ: Statistical differences 120-h after match condition (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
14 pages, 3434 KiB  
Article
A Nuclear Magnetic Resonance (NMR)- and Mass Spectrometry (MS)-Based Saturation Kinetics Model of a Bryophyllum pinnatum Decoction as a Treatment for Kidney Stones
by Candus Chik, Anne-Laure Larroque, Yuan Zhuang, Shane Feinstein, Donald L. Smith, Sero Andonian, Aimee K. Ryan, Bertrand Jean-Claude and Indra R. Gupta
Int. J. Mol. Sci. 2024, 25(10), 5280; https://doi.org/10.3390/ijms25105280 - 12 May 2024
Viewed by 1545
Abstract
Bryophyllum pinnatum (BP) is a medicinal plant used to treat many conditions when taken as a leaf juice, leaves in capsules, as an ethanolic extract, and as herbal tea. These preparations have been chemically analyzed except for decoctions derived from boiled green leaves. [...] Read more.
Bryophyllum pinnatum (BP) is a medicinal plant used to treat many conditions when taken as a leaf juice, leaves in capsules, as an ethanolic extract, and as herbal tea. These preparations have been chemically analyzed except for decoctions derived from boiled green leaves. In preparation for a clinical trial to validate BP tea as a treatment for kidney stones, we used NMR and MS analyses to characterize the saturation kinetics of the release of metabolites. During boiling of the leaves, (a) the pH decreased to 4.8 within 14 min and then stabilized; (b) regarding organic acids, citric and malic acid were released with maximum release time (tmax) = 35 min; (c) for glycoflavonoids, quercetin 3-O-α-L-arabinopyranosyl-(1 → 2)-α-L-rhamnopyranoside (Q-3O-ArRh), myricetin 3-O-α-L-arabinopyranosyl-(1 → 2)-α-L-rhamnopyranoside (M-3O-ArRh), kappinatoside, myricitrin, and quercitrin were released with tmax = 5–10 min; and (d) the total phenolic content (TPC) and the total antioxidant capacity (TAC) reached a tmax at 55 min and 61 min, respectively. In summary, 24 g of leaves boiled in 250 mL of water for 61 min ensures a maximal release of key water-soluble metabolites, including organic acids and flavonoids. These metabolites are beneficial for treating kidney stones because they target oxidative stress and inflammation and inhibit stone formation. Full article
(This article belongs to the Special Issue Bioactives in Fruit and Vegetables)
Show Figures

Figure 1

Figure 1
<p>Kinetics of pH of <span class="html-italic">B. pinnatum</span> decoction during boiling. Data shown are means ± standard deviation (SD) from 5 independent experiments. After 14 min (shown by red dotted line), the pH of the decoction stabilized to an average of 4.8.</p>
Full article ">Figure 2
<p>Identification of malic acid and citric acid in BP decoction as characterized by <sup>1</sup>H NMR. The decoction was spiked with 2.25 mg/mL of either malic acid, citric acid, or both. An increase in peak intensity was observed in the chemical shift range of 2.38–2.85 ppm for both malic acid and citric acid as indicated by the black bracket. Additionally, malic acid had a unique singlet observed at 4.18 ppm denoted by the orange arrow.</p>
Full article ">Figure 3
<p>Combined kinetics of release of citric and malic acid into the <span class="html-italic">B. pinnatum</span> decoction shown as area under the curve versus boiling time. Within 35 min, citric acid and malic acid were maximally released into the decoction (t<sub>max</sub> shown by red dotted line). Data shown are means ± SD from 5 independent experiments.</p>
Full article ">Figure 4
<p>Kinetics of release of gallic acid into the <span class="html-italic">B. pinnatum</span> decoction as characterized by (<b>a</b>) <sup>1</sup>H NMR and (<b>b</b>) LC-MS/MS. The saturation of gallic acid in solution was predicted to occur at approximately 13 and 10 h by <sup>1</sup>H NMR and LC-MS/MS, respectively. <sup>1</sup>H NMR and MS data are means ± SD from 3 and 5 independent experiments, respectively.</p>
Full article ">Figure 5
<p>Kinetics of release of flavonoids conjugated with disaccharides into the <span class="html-italic">B. pinnatum</span> decoction were characterized by LC-MS/MS. (<b>a</b>) Q-3O-ArRh, (<b>b</b>) M-3O-ArRh, and (<b>c</b>) kappinatoside identified at <span class="html-italic">m</span>/<span class="html-italic">z</span> 579 [M−H]<sup>−</sup>, 595 [M−H]<sup>−</sup>, and 563 [M−H]<sup>−</sup>, respectively. Maximal release of these flavonoids was observed between 5 and 10 min (shown by red dotted lines). Data shown are means ± SD from 5 independent experiments.</p>
Full article ">Figure 6
<p>Kinetics of release of flavonoids conjugated with monosaccharides (<b>a</b>) myricitrin and (<b>b</b>) quercitrin into the <span class="html-italic">B. pinnatum</span> decoction as characterized by LC-MS/MS at <span class="html-italic">m</span>/<span class="html-italic">z</span> 463 [M−H]<sup>−</sup> and 447 [M−H]<sup>−</sup>, respectively. Data shown are means ± SD from 5 independent experiments.</p>
Full article ">Figure 7
<p>(<b>a</b>) Kinetics of release of total phenolic content into the <span class="html-italic">B. pinnatum</span> decoction. Maximal release was observed within 55 min at 0.4 mM catechin equivalent (shown by red dotted line). (<b>b</b>) Kinetics of release of total antioxidant capacity. Maximal release was observed within 61 min at 4.7 mM Trolox equivalent (shown by red dotted line). Data shown are means ± SD from 3 independent experiments.</p>
Full article ">Figure 8
<p>Key metabolic signature of <span class="html-italic">Bryophyllum pinnatum</span> decoction for clinical use. The kinetics of the total antioxidant capacity were used to define the duration of boiling of 61 min.</p>
Full article ">Figure A1
<p>Chemical structures of carboxylic acids and glycoflavonoids identified BP decoction. Their kinetics of release were monitored by <sup>1</sup>H NMR and LC-MS/MS.</p>
Full article ">Figure A2
<p>Medicinal metabolites identified by LC-MS/MS from the chromatogram of BP decoction.</p>
Full article ">
17 pages, 876 KiB  
Review
Vitamins in Gynecologic Malignancies
by Natalia Wierzbowska, Tomasz Olszowski, Dariusz Chlubek, Mateusz Kozłowski and Aneta Cymbaluk-Płoska
Nutrients 2024, 16(9), 1392; https://doi.org/10.3390/nu16091392 - 5 May 2024
Cited by 1 | Viewed by 2404
Abstract
The combination of vitamin A and D derivatives with classical chemotherapeutic treatments results in more satisfactory outcomes. The use of drug combinations, such as 9cUAB130 with carboplatin and cisplatin with TAC-101, shows enhanced cytotoxic effects and reductions in ovarian tumor volume compared to [...] Read more.
The combination of vitamin A and D derivatives with classical chemotherapeutic treatments results in more satisfactory outcomes. The use of drug combinations, such as 9cUAB130 with carboplatin and cisplatin with TAC-101, shows enhanced cytotoxic effects and reductions in ovarian tumor volume compared to single-drug treatments. Combining cisplatin with calcitriol and progesterone increases VDR expression, potentially enhancing the effectiveness of anticancer therapy in ovarian cancer. The effectiveness of vitamin derivatives in anticancer treatment may vary depending on the characteristics of the tumor and the cell line from which it originated. An increase in thiamine intake of one unit is associated with an 18% decrease in HPV infection. Higher intake of vitamin C by 50 mg/day is linked to a lower risk of cervical neoplasia. Beta-carotene, vitamin C, and vitamin E are associated with risk reductions of 12%, 15%, and 9% in endometrial cancer, respectively. A balanced daily intake of vitamins is important, as both deficiency and excess can influence cancer development. It has been observed that there is a U-shaped relationship between group B vitamins and metabolic markers and clinical outcomes. Full article
(This article belongs to the Special Issue Micronutrients in Women’s Health and Disease)
Show Figures

Figure 1

Figure 1
<p>Signaling pathway of vitamin A metabolites. RA—retinoic acid, ATRA—all-trans retinoic acid, CRBP—cellular retinol binding proteins, CRABP—cellular retinoic acid binding proteins, RAR—retinoic acid receptor, RXR—retinoid X receptor, RARE—retinoic acid response element.</p>
Full article ">Figure 2
<p>Signaling pathway of the active form of vitamin D. 1α,25(OH)₂D₃—calcitriol, VDR—vitamin D receptor, RXR—retinoid-X-receptor, VDRE—vitamin D response element.</p>
Full article ">
22 pages, 3038 KiB  
Article
Benchmarking Large Language Model (LLM) Performance for Game Playing via Tic-Tac-Toe
by Oguzhan Topsakal and Jackson B. Harper
Electronics 2024, 13(8), 1532; https://doi.org/10.3390/electronics13081532 - 17 Apr 2024
Viewed by 3061
Abstract
This study investigates the strategic decision-making abilities of large language models (LLMs) via the game of Tic-Tac-Toe, renowned for its straightforward rules and definitive outcomes. We developed a mobile application coupled with web services, facilitating gameplay among leading LLMs, including Jurassic-2 Ultra by [...] Read more.
This study investigates the strategic decision-making abilities of large language models (LLMs) via the game of Tic-Tac-Toe, renowned for its straightforward rules and definitive outcomes. We developed a mobile application coupled with web services, facilitating gameplay among leading LLMs, including Jurassic-2 Ultra by AI21, Claude 2.1 by Anthropic, Gemini-Pro by Google, GPT-3.5-Turbo and GPT-4 by OpenAI, Llama2-70B by Meta, and Mistral Large by Mistral, to assess their rule comprehension and strategic thinking. Using a consistent prompt structure in 10 sessions for each LLM pair, we systematically collected data on wins, draws, and invalid moves across 980 games, employing two distinct prompt types to vary the presentation of the game’s status. Our findings reveal significant performance variations among the LLMs. Notably, GPT-4, GPT-3.5-Turbo, and Llama2 secured the most wins with the list prompt, while GPT-4, Gemini-Pro, and Mistral Large excelled using the illustration prompt. GPT-4 emerged as the top performer, achieving victory with the minimum number of moves and the fewest errors for both prompt types. This research introduces a novel methodology for assessing LLM capabilities using a game that can illuminate their strategic thinking abilities. Beyond enhancing our comprehension of LLM performance, this study lays the groundwork for future exploration into their utility in complex decision-making scenarios, offering directions for further inquiry and the exploration of LLM limits within game-based frameworks. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>Left</b>) the screen to select the number of games, players, and the prompt type. (<b>Right</b>) the screen displays how the game progresses.</p>
Full article ">Figure 2
<p>The illustration of app and web service interactions to play Tic-Tac-Toe.</p>
Full article ">Figure 3
<p>This chart, based on the ‘list’ prompt, shows Tic-Tac-Toe game outcomes where each LLM faced six others and itself, playing each opponent 10 times (70 games total). Blue bars indicate the LLM playing as the first player (X) and orange bars for the second player (O).</p>
Full article ">Figure 4
<p>This chart, based on the ‘illustration’ prompt, shows Tic-Tac-Toe game outcomes where each LLM faced six others and itself, playing each opponent 10 times (70 games total). Blue bars indicate the LLM playing as the first player (X) and orange bars for the second player (O).</p>
Full article ">Figure 5
<p>Moves per result when list type of prompt is used.</p>
Full article ">Figure 6
<p>Moves per result when illustration type of prompt is used.</p>
Full article ">
16 pages, 1582 KiB  
Article
Effects of a Curcumin/Silymarin/Yeast-Based Mycotoxin Detoxifier on Redox Status and Growth Performance of Weaned Piglets under Field Conditions
by Vasileios G. Papatsiros, Georgios I. Papakonstantinou, Nikolaos Voulgarakis, Christos Eliopoulos, Christina Marouda, Eleftherios Meletis, Irene Valasi, Polychronis Kostoulas, Dimitrios Arapoglou, Insaf Riahi, Georgios Christodoulopoulos and Dimitra Psalla
Toxins 2024, 16(4), 168; https://doi.org/10.3390/toxins16040168 - 25 Mar 2024
Cited by 2 | Viewed by 2216
Abstract
The aim of this in vivo study was to investigate the effects of a novel mycotoxin detoxifier whose formulation includes clay (bentonite and sepiolite), phytogenic feed additives (curcumin and silymarin) and postbiotics (yeast products) on the health, performance and redox status of weaned [...] Read more.
The aim of this in vivo study was to investigate the effects of a novel mycotoxin detoxifier whose formulation includes clay (bentonite and sepiolite), phytogenic feed additives (curcumin and silymarin) and postbiotics (yeast products) on the health, performance and redox status of weaned piglets under the dietary challenge of fumonisins (FUMs). The study was conducted in duplicate in the course of two independent trials on two different farms. One hundred and fifty (150) weaned piglets per trial farm were allocated into two separate groups: (a) T1 (control group): 75 weaned piglets received FUM-contaminated feed and (b) T2 (experimental group): 75 weaned piglets received FUM-contaminated feed with the mycotoxin-detoxifying agent from the day of weaning (28 days) until 70 days of age. Thiobarbituric acid reactive substances (TBARSs), protein carbonyls (CARBs) and the overall antioxidant capacity (TAC) were assessed in plasma as indicators of redox status at 45 and 70 days of age. Furthermore, mortality and performance parameters were recorded at 28, 45 and 70 days of age, while histopathological examination was performed at the end of the trial period (day 70). The results of the present study reveal the beneficial effects of supplementing a novel mycotoxin detoxifier in the diets of weaners, including improved redox status, potential hepatoprotective properties and enhanced growth performance. Full article
(This article belongs to the Section Mycotoxins)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Liver (Farm 1, T1 control group piglet). <b>Left</b>: mild degeneration of hepatocytes seen as discoloration (black arrows) and mild periportal infiltration by lymphocytes and plasma (black arrowheads), magnification × 40. <b>Right</b>: without pathological changes, magnification × 40. Hematoxylin–eosin stain.</p>
Full article ">Figure 2
<p>Intestine. <b>Left</b> (Farm 2, T1 control group piglet): mild infiltration of the lamina propria by lymphocytes and plasma cells (indicated as a) and necrosis of the epithelium (indicated as b), magnification × 100. <b>Right</b> (Farm 2, T2 experimental group piglet): mild infiltration of the lamina propria by lymphocytes and plasma cells (indicated as a) without necrosis—intact epithelium (black arrows), magnification × 100. Hematoxylin–eosin stain.</p>
Full article ">Figure 3
<p>Kidney (Farm 1, T1 control group piglet): (<b>left,</b> magnification × 100 and <b>right</b>, magnification × 200) glomerulonephritis characterized by mild hypercellularity mononuclear (black arrows) and hyperemia of glomeruli (white arrows). Hematoxylin–eosin stain.</p>
Full article ">
Back to TopTop